Nanoparticulate systems for brain delivery of drugs.

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750 · see citing works

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693 · see citing works

Brain drug delivery of small molecules using immunoliposomes

Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 656 · see citing works

A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier

Dehouck, B., Fénart, L., Dehouck, M., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 568 · see citing works

An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro

Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 548 · see citing works

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538 · see citing works

Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521 · see citing works

Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful Stimuli

Frederickson, R. C. A., Burgis, V., & Edwards, J. D. (1977) · Science · doi:10.1126/science.561998 · Cited by 379 · see citing works

Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358 · see citing works

Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352 · see citing works

Pharmacokinetics and distribution of a biodegradable drug-carrier

Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Campeneere, D. D.-D., & Speiser, P. P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305 · see citing works

The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System

Begley, D. J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb07112.x · Cited by 291 · see citing works

The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System

Nerurkar, M. M., Burton, P. S., & Borchardt, R. T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016033702220 · Cited by 287 · see citing works

Drug Transfer Across the Blood‐Brain Barrier: Correlation Between In Vitro and In Vivo Models

Dehouck, M., Jolliet, P., Brée, F., Fruchart, J., Cecchelli, R., & Tillement, J. P. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10055.x · Cited by 286 · see citing works

Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier

Schröeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275 · see citing works

The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908

Illum, L., Davis, S. S., Müller, R. H., Mak, E., & West, P. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90138-x · Cited by 273 · see citing works

Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes.

Dehouck, B., Dehouck, M., Fruchart, J., & Cecchelli, R. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.2.465 · Cited by 234 · see citing works

Reversal of multidrug resistance by surfactants

Woodcock, D., Linsenmeyer, M. E., Chojnowski, G. M., Kriegler, A., Nink, V., Webster, L., & Sawyer, W. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.217 · Cited by 233 · see citing works

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80–coated polybutylcyanoacrylate nanoparticles: Anin situbrain perfusion study

Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229 · see citing works

Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles

Couvreur, P., Kante, B., Grislain, L., Roland, M., & Speiser, P. P. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710717 · Cited by 217 · see citing works

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

Olivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213 · see citing works

Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles

Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196 · see citing works

Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrierin vivoandin vitro

Alyaudtin, R. N., Reichel, A., Löbenberg, R., Ramge, P., Kreuter, J., & Begley, D. J. (2001) · Journal of drug targeting · doi:10.3109/10611860108997929 · Cited by 166 · see citing works

Structural and Functional Variations in Capillary Systems within the Braina

Fenstermacher, J. D., Gross, P. M., Sposito, N. M., Acuff, V., Pettersen, S. E., & Gruber, K. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb51416.x · Cited by 162 · see citing works

Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants

Tröster, S. D., Müller, U., & Kreuter, J. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90047-8 · Cited by 161 · see citing works

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

Kattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153 · see citing works

Regional Brain Blood Flow, Blood Volume, and Haematocrit Values in the Adult Rat

Cremer, J. E., & Seville, M. P. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.35 · Cited by 145 · see citing works

Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections

Schröder, U., & Sabel, B. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01375-x · Cited by 144 · see citing works

Low‐Density Lipoprotein Receptor on Endothelium of Brain Capillaries

Méresse, S., Delbart, C., Fruchart, J., & Cecchelli, R. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07340.x · Cited by 143 · see citing works

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

Friese, A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00073-9 · Cited by 140 · see citing works

Effect of the Nonionic Surfactant Poloxamer 338 on the Fate and Deposition of Polystyrene Microspheres Following Intravenous Administration

Illum, L., & Davis, S. S. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600720933 · Cited by 117 · see citing works

Efficacy of Oral Dalargin-loaded Nanoparticle Delivery across the Blood–Brain Barrier

Schröeder, U., Sommerfeld, P., & Sabel, B. A. (1998) · Peptides · doi:10.1016/s0196-9781(97)00474-9 · Cited by 106 · see citing works

Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers

Borchard, G., Audus, K. L., Shi, F., & Kreuter, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90372-7 · Cited by 105 · see citing works

Brain distribution spaces of mannitol-3H, inulin-14C, and dextran-14C in the rat

Wb, S., & Oldendorf, W. (1971) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1971.221.1.214 · Cited by 82 · see citing works

Enhanced Brain Tumor Selectivity of Cationic Magnetic Polysaccharide Microspheres

Pulfer, S. K., & Gallo, J. M. (1998) · Journal of drug targeting · doi:10.3109/10611869808997896 · Cited by 70 · see citing works

Body distribution of 3HH-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after I.V. injections to mice

Schröeder, U., Schröeder, H., & Sabel, B. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00619-0 · Cited by 66 · see citing works

Modulation of Blood-Brain Barrier Permeability

Rapoport, S. I. (1996) · Journal of drug targeting · doi:10.3109/10611869609015962 · Cited by 54 · see citing works

Ultrastructure of Brain Endothelium

Brightman, M. (1992) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-76894-1_1 · Cited by 45 · see citing works

Targeted delivery of DNA by liposomes and polymers

Zhou, X., & Huang, L. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90082-3 · Cited by 41 · see citing works

Expression of receptors for native and chemically modified low‐density lipoproteins in brain microvessels

Lucarelli, M., Gennarelli, M., Cardelli, P., Novelli, G., Scarpa, S., Dallapiccola, B., & Ström, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01435-4 · Cited by 39 · see citing works

Spinal subarachnoid perfusion of rhesus monkeys

Kessler, J., Fenstermacher, J. D., & Owens, E. (1976) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1976.230.3.614 · Cited by 38 · see citing works

Genetic differences in daily rhythms of pain sensivity in mice

Castellano, C., Puglisi‐Allegra, S., Renzi, P., & Oliverio, A. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90135-2 · Cited by 36 · see citing works

Drug Entry Into the Brain and Its Pharmacologic Manipulation

Greig, N. H. (1992) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-76894-1_20 · Cited by 31 · see citing works

Characterization of the Scavenger Receptor on Bovine Cerebral Endothelial Cells In Vitro

de Vries, H. E., Kuiper, J., Boer, A. G. D., van Berkel, T. J. C., & Breimer, D. D. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09821.x · Cited by 30 · see citing works

Biodistribution of calcitonin encapsulated in liposomes in mice with particular reference to the central nervous system

Chen, D., & Lee, K. H. (1993) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(93)90021-y · Cited by 30 · see citing works

Circadian Phase-Dependent Antinociceptive Reaction in Mice Determined by the Hot-Plate test and the Tail-Flick Test After Intravenous Injection of Dalargin-Loaded Nanoparticles

Ramge, P., Kreuter, J., & Lemmer, B. (1999) · Chronobiology International · doi:10.3109/07420529909016944 · Cited by 27 · see citing works

Do Ultra-Low Frequency ULF) Magnetic Fields Affect the Blood-Brain Barrier?

Begley, D. J., & Kreuter, J. (1999) · Springer eBooks · doi:10.1007/978-1-4615-5051-8_49 · Cited by 6 · see citing works

Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles

Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891 · see citing works

Drug Delivery Systems: Entering the Mainstream

Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · see citing works

Drug delivery and nanoparticles: Applications and hazards

de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,854 · see citing works

Factors affecting the clearance and biodistribution of polymeric nanoparticles

Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699 · see citing works

Nanoparticles in cancer therapy and diagnosis

Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,040 · see citing works

Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging

Omid Veiseh, A., Gunn, J., & Zhang, M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.002 · Cited by 1,836 · see citing works

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791 · see citing works

Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment

Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758 · see citing works

Nanocarriers’ entry into the cell: relevance to drug delivery

Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,549 · see citing works

Nanosuspensions in drug delivery

Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,528 · see citing works

Nanoparticles – known and unknown health risks

Hoet, P., Brüske‐Hohlfeld, I., & Salata, O. V. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-12 · Cited by 1,407 · see citing works

Biodegradable nanoparticles for drug delivery and targeting

Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324 · see citing works

Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 1)

Honary, S., & Zahir, F. (2013) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i2.19 · Cited by 1,144 · see citing works

Therapeutic efficacy of nanoparticles and routes of administration

Chenthamara, D., Sadhasivam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,073 · see citing works

Magnetic nanoparticles for theragnostics

Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,029 · see citing works

Nanomedicine(s) under the Microscope

Duncan, R., & Gaspar, R. S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 985 · see citing works

Toxicology of nanoparticles: A historical perspective

Oberdörster, G., Stone, V., & Donaldson, K. (2007) · Nanotoxicology · doi:10.1080/17435390701314761 · Cited by 965 · see citing works

Nanoparticles in cancer therapy and diagnosis

Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 958 · see citing works

Nanosuspensions: a promising drug delivery strategy

Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 907 · see citing works

Nanoparticles in cellular drug delivery

Faraji, A. H., & Wipf, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.043 · Cited by 907 · see citing works

Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective

Ratnam, D. V., Ankola, D. D., Bhardwaj, V., Sahana, D. K., & Kumar, M. N. V. R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.015 · Cited by 885 · see citing works

Crossing the blood-brain barrier with nanoparticles

Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837 · see citing works

Nanodiamond Particles: Properties and Perspectives for Bioapplications

Schrand, A. M., Hens, S. A. C., & Shenderova, O. A. (2009) · Critical reviews in solid state and materials sciences/CRC critical reviews in solid state and materials sciences · doi:10.1080/10408430902831987 · Cited by 803 · see citing works

Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells

Vinogradov, S. V., Bronich, T. K., & Kabanov, A. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00245-9 · Cited by 776 · see citing works

Nanostructured lipid carriers: Promising drug delivery systems for future clinics

Beloqui, A., Solinís, M. Á., Rodríguez‐Gascón, A., Almeida, A. J., & Véronique Préat, A. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 790 · see citing works

apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain

Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · see citing works

Deposition and biokinetics of inhaled nanoparticles

Geiser, M., & Kreyling, W. G. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-2 · Cited by 747 · see citing works

Parameters influencing the stealthiness of colloidal drug delivery systems

Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740 · see citing works

Transport of drugs across the blood–brain barrier by nanoparticles.

Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715 · see citing works

Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases

Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708 · see citing works

Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines

Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685 · see citing works

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities

Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679 · see citing works

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617 · see citing works

Potential of solid lipid nanoparticles in brain targeting.

Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615 · see citing works

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)

Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591 · see citing works

Interaction of Nanoparticles with Cells

Mailänder, V., & Landfester, K. (2009) · Biomacromolecules · doi:10.1021/bm900266r · Cited by 576 · see citing works

Antibacterial activity of chitosan tripolyphosphate nanoparticles loaded with various metal ions

Du, W., Niu, S.-S., Xu, Y., Xu, Z., & Fan, C.-L. (2008) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2008.07.039 · Cited by 575 · see citing works

Polymeric nanoparticles for drug delivery to the central nervous system

Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 569 · see citing works

Optical and MRI Multifunctional Nanoprobe for Targeting Gliomas

Omid Veiseh, A., Sun, C., Gunn, J., Kohler, N., Gabikian, P., Lee, D., Bhattarai, N., Ellenbogen, R. G., Sze, R. W., Hallahan, A. R., et al. (2005) · Nano Letters · doi:10.1021/nl0502569 · Cited by 564 · see citing works

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554 · see citing works

Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 536 · see citing works

Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications

Vauthier, C., Dubernet, C., Fattal, E., Pinto‐Alphandary, H., & Couvreur, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00041-3 · Cited by 528 · see citing works

Nanoparticles and targeted drug delivery in cancer therapy

Bahrami, B., Hojjat‐Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi‐Niaragh, F. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.015 · Cited by 513 · see citing works

Nanomaterials for Neural Interfaces

Kotov, N. A., Winter, J. O., Clements, I. P., Jan, E., Timko, B. P., Campidelli, S., Pathak, S., Mazzatenta, A., Lieber, C. M., Prato, M., et al. (2009) · Advanced Materials · doi:10.1002/adma.200801984 · Cited by 504 · see citing works

Magnetic nanoparticle drug delivery systems for targeting tumor

Mody, V. V., Cox, A. G., Shah, S., Singh, A., Wesley, B., & Parihar, H. S. (2013) · Applied Nanoscience · doi:10.1007/s13204-013-0216-y · Cited by 498 · see citing works

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

Bhaskar, S. M. M., Tian, F., Stoeger, T., Kreyling, W. G., de la Fuente, J. M., Grazú, V., Borm, P. J. A., Estrada, G. G., Ntziachristos, V., & Razansky, D. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-3 · Cited by 497 · see citing works

Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier

Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592 · see citing works

Nanoparticles in Drug Delivery: From History to Therapeutic Applications

Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468 · see citing works

Small Bioactive Peptides for Biomaterials Design and Therapeutics

Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 461 · see citing works

Sociogenomics: social life in molecular terms

Robinson, G. E., Grozinger, C. M., & Whitfield, C. W. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1575 · Cited by 456 · see citing works

Nanocarriers: Promising Vehicle for Bioactive Drugs

Rawat, M. S., Singh, D., Saraf, S., & Saraf, S. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1790 · Cited by 449 · see citing works

Drug transport to brain with targeted nanoparticles

Olivier, J. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.108 · Cited by 445 · see citing works

Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles

Bootz, A., Vogel, V., Schubert, D., & Kreuter, J. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00193-0 · Cited by 431 · see citing works

Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges

Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430 · see citing works

Active targeting of brain tumors using nanocarriers

Béduneau, A., Saulnier, P., & Benoît, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 423 · see citing works

Catalytic properties and biomedical applications of cerium oxide nanoparticles

Walkey, C., Das, S., Seal, S., Erlichman, J. S., Heckman, K. L., Ghibelli, L., Traversa, E., McGinnis, J. F., & Self, W. T. (2014) · Environmental Science Nano · doi:10.1039/c4en00138a · Cited by 410 · see citing works

Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease

Roney, C. A., Kulkarni, P. V., Arora, V., Antich, P. P., Bonte, F. J., Wu, A., Mallikarjuana, N. N., Manohar, S. K., Liang, H., Kulkarni, A. R., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.024 · Cited by 408 · see citing works

Magnetic Nanoparticles and Their Applications in Medicine

Duguet, É., Vasseur, S., Mornet, S., & Devoisselle, J. (2006) · Nanomedicine · doi:10.2217/17435889.1.2.157 · Cited by 396 · see citing works

Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain

Liu, H.-L., Hua, M., Yang, H., Huang, C.-Y., Chu, P., Wu, J.-S., Tseng, I.-C., Wang, J., Yen, T., Chen, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003388107 · Cited by 396 · see citing works

Neuroscience nanotechnology: progress, opportunities and challenges

Silva, G. A. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1827 · Cited by 383 · see citing works

Nanodrugs: pharmacokinetics and safety

Onoue, S., Yamada, S., & Chan, H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s38378 · Cited by 383 · see citing works

Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration

Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 381 · see citing works

Specific Targeting of Brain Tumors with an Optical/Magnetic Resonance Imaging Nanoprobe across the Blood-Brain Barrier

Omid Veiseh, A., Sun, C., Fang, C., Bhattarai, N., Gunn, J., Kievit, F. M., Du, K. N., Pullar, B. J., Lee, D., Ellenbogen, R. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1157 · Cited by 378 · see citing works

Nanogels for Oligonucleotide Delivery to the Brain

Vinogradov, S. V., Batrakova, E. V., & Kabanov, A. V. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034164r · Cited by 379 · see citing works

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363 · see citing works

Drug delivery from gelatin-based systems

Foox, M., & Zilberman, M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1037272 · Cited by 361 · see citing works

Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies

Han, L., & Jiang, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.023 · Cited by 358 · see citing works

Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility

Fournier, E., Passirani, C., Montero‐Menei, C. N., & Benoît, J. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00161-3 · Cited by 353 · see citing works

Nanomedicines and nanotoxicology: some physiological principles

Garnett, M. C., & Kallinteri, P. (2006) · Occupational Medicine · doi:10.1093/occmed/kql052 · Cited by 352 · see citing works

Current approaches to enhance CNS delivery of drugs across the brain barriers

Lu, C.-T., Zhao, Y.-Z., Wong, H. L., Cai, J., Peng, L., & Tian, X.-Q. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s61288 · Cited by 350 · see citing works

Drug nanocrystals: in vivo performances.

Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347 · see citing works

Applications of nanotechnology in drug delivery to the central nervous system

Saeedi, M., Eslamifar, M., Khezri, K., & Dizaj, S. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.133 · Cited by 342 · see citing works

Polymeric Nanoparticles for Delivery of Natural Bioactive Agents: Recent Advances and Challenges

Elmowafy, M., Shalaby, K., Elkomy, M. H., Alsaidan, O. A., Gomaa, H. A. M., Abdelgawad, M. A., & Mostafa, E. M. (2023) · Polymers · doi:10.3390/polym15051123 · Cited by 341 · see citing works

Dynamic self-organization phenomena in complex ionized gas systems: new paradigms and technological aspects

Vladimirov, S. V., & Ostrikov, K. (2004) · Physics Reports · doi:10.1016/j.physrep.2003.12.003 · Cited by 332 · see citing works

Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer

Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331 · see citing works

Role of metal dyshomeostasis in Alzheimer's disease

Bonda, D., Lee, H., Blair, J. A., Zhu, X., Perry, G. L., & Smith, M. A. (2011) · Metallomics · doi:10.1039/c0mt00074d · Cited by 316 · see citing works

Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB

Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318 · see citing works

Protein nanoparticle: A unique system as drug delivery vehicles

Jahanshahi, M., & Babaei, Z. (2008) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.4314/ajb.v7i25.59701 · Cited by 314 · see citing works

Building nanostructures using RAFT polymerization

Boyer, C. A., Stenzel, M. H., & Davis, T. P. (2010) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.24482 · Cited by 314 · see citing works

Protein Nanoparticles: Promising Platforms for Drug Delivery Applications

Jain, A., Singh, S. K., Arya, S. K., Kundu, S. C., & Kapoor, S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01098 · Cited by 309 · see citing works

Strategies for transporting nanoparticles across the blood–brain barrier

Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308 · see citing works

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305 · see citing works

Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues

Brambilla, D., Droumaguet, B. L., Nicolas, J., Hashemi, S. H., Wu, L., Moghimi, S. M., Couvreur, P., & Andrieux, K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.03.008 · Cited by 293 · see citing works

Ultrafine particles in the urban air: to the respiratory tract--and beyond?

Oberdörster, G., & Utell, M. J. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.110-1240959 · Cited by 287 · see citing works

Nano carriers for drug transport across the blood–brain barrier

Li, X.-M., Tsibouklis, J., Weng, T., Zhang, B.-N., Yin, G.-Q., Feng, G.-Z., Cui, Y.-D., Savina, I., Mikhalovska, L., Sandeman, S., et al. (2017) · Journal of drug targeting (Print) · doi:10.1080/1061186x.2016.1184272 · Cited by 217 · see citing works

Delivery of peptide and protein drugs over the blood–brain barrier

Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279 · see citing works

Nanomedicine in the diagnosis and therapy of neurodegenerative disorders

Kabanov, A. V., & Gendelman, H. E. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.014 · Cited by 277 · see citing works

Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma

Zhou, J., Patel, T., Sirianni, R. W., Strohbehn, G. W., Zheng, M., Duong, N. T., Schafbauer, T., Huttner, A. J., Huang, Y. H., Carson, R. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304504110 · Cited by 272 · see citing works

Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles

Gao, K., & Jiang, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.040 · Cited by 269 · see citing works

The Handbook of Nanomedicine

Jain, K. K. (2008) · Springer eBooks · doi:10.1007/978-1-4939-6966-1 · Cited by 268 · see citing works

Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration

Nance, E. A., Zhang, C., Shih, T.-Y., Xu, Q., Schuster, B. S., & Hanes, J. S. (2014) · ACS Nano · doi:10.1021/nn504210g · Cited by 266 · see citing works

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain

Kreuter, J., Hekmatara, T., Dreis, S., Vogel, T., Gelperina, S. E., & Langer, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.012 · Cited by 263 · see citing works

Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model

Wagner, S., Zensi, A., Wien, S., Tschickardt, S., Maier, W., Vogel, T., Worek, F., Pietrzik, C. U., Kreuter, J., & von Briesen, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032568 · Cited by 260 · see citing works

Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

Ulbrich, K., Knobloch, T., & Kreuter, J. (2011) · Journal of Drug Targeting · doi:10.3109/10611861003734001 · Cited by 259 · see citing works

Drug Delivery to the Brain across the Blood–Brain Barrier Using Nanomaterials

Tsou, Y., Zhang, X., Zhu, H., Syed, S., & Xu, X. (2017) · Small · doi:10.1002/smll.201701921 · Cited by 259 · see citing works

Electrohydrodynamic atomization for biodegradable polymeric particle production

Xie, J., Lim, L. K., Phua, Y., Hua, J., & Wang, C. (2006) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2006.06.037 · Cited by 251 · see citing works

Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.

Vykhodtseva, N., McDannold, N., & Hynynen, K. (2008) · Ultrasonics · doi:10.1016/j.ultras.2008.04.004 · Cited by 251 · see citing works

Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Ramasamy, M., & Suresh, B. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.04.001 · Cited by 245 · see citing works

Cytotoxicity of water-soluble fullerene in vascular endothelial cells

Yamawaki, H., & Iwai, N. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00481.2005 · Cited by 243 · see citing works

Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles

Kanazawa, T., Akiyama, F., Kakizaki, S., Takashima, Y., & Seta, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.036 · Cited by 242 · see citing works

Application of nanoparticles for the delivery of drugs to the brain

Kreuter, J. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.014 · Cited by 107 · see citing works

Transport of drugs across the blood–brain barrier by nanoparticles.

Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715 · see citing works

Use of nanoparticles to deliver therapeutics to the CNS

Kreuter, J. (2010) · Frontiers in Pharmacology · doi:10.3389/conf.fphar.2010.02.00024

Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain

Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 363 · see citing works

Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (bbb).

Kreuter, J. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2012.692491 · Cited by 172 · see citing works